During development, nerve growth cones are guided by a balance of positive and negative cues that ensure robust axon outgrowth and fine-tuned control of direction and trajectory (Stoeckli and Landmesser 1998). In contrast to the embryonic environment, the injured adult central nervous system (CNS) in mammals is overwhelmingly inhibitory for axon outgrowth, severely limiting nerve regeneration (Fry 2001). The inability of axons to regrow after CNS injury has profound medical consequences. This is most evident in the lack of recovery from spinal cord injuries, which result in life-long loss of function for millions of people worldwide (Geisler et al. 2001;,Sekhon and Fehlings 2001). The pathology of brain trauma, stroke, and progressive multiple sclerosis are also negatively impacted by limitations on axon outgrowth in the CNS. The discovery of the molecular mechanisms that render the CNS such an inhospitable environment for nerve regeneration may provide new approaches to enhance recovery of nerve damage after injury or disease (Kwon and Tetzlaff 2001).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Asher RA, Morgenstern DA, Moon LD, Fawcett JW (2001) Chondroitin sulphate pro-teoglycans: inhibitory components of the glial scar. Prog Brain Res 132:611–619
Bandtlow CE, Loschinger J (1997) Developmental changes in neuronal responsiveness to the CNS myelin-associated neurite growth inhibitor NI-35/250. Eur J Neurosci 9:2743–2752
Bartsch S, Montag D, Schachner M, Bartsch U (1997) Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein (MAG). Brain Res 762:231–234
Becker T, Anliker B, Becker CG, Taylor J, Schachner M, Meyer RL, Bartsch U (2000) Tenascin-R inhibits regrowth of optic fibers in vitro and persists in the optic nerve of mice after injury. Glia 29:330–346
Benfey M, Aguayo AJ (1982) Extensive elongation of axons from rat brain into peripheral nerve grafts. Nature 296:150–152
Bovolenta P, Fernaud-Espinosa I (2000) Nervous system proteoglycans as modulators of neurite outgrowth. Prog Neurobiol 61:113–132
Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636–640
Brittis PA, Flanagan JG (2001) Nogo domains and a Nogo receptor: implications for axon regeneration. Neuron 30:11–14
Brosamle C, Huber AB, Fiedler M, Skerra A, Schwab ME (2000) Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J Neurosci 20:8061–8068
Cai D, Shen Y, De Bellard M, Tang S, Filbin MT (1999) Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMPdependent mechanism. Neuron 22:89–101
Caroni P, Schwab ME (1988a) Antibody against myelin-associated inhibitor of neurite growth neutralizes non-permissive substrate properties of CNS white matter. Neuron 1:85–96
Caroni P, Schwab ME (1988b) Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol 106:1281–1288
Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403:434–439
Chiavegatto S, Sun J, Nelson RJ, Schnaar RL (2000) A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. Exp Neurol 166:227–234
Collins BE, Kiso M, Hasegawa A, Tropak MB, Roder JC, Crocker PR, Schnaar RL (1997) Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem 272:16889–16895
Crocker PR, Varki A (2001) Siglecs in the immune system. Immunology 103:137–145
Crocker PR, Kelm S, Hartnell A, Freeman S, Nath D, Vinson M, Mucklow S (1996) Sialoadhesin and related cellular recognition molecules of the immunoglobulin superfamily. Biochem Soc Trans 24:150–156
Crocker PR, Clark EA, Filbin M, Gordon S, Jones Y, Kehrl JH, Kelm S, Le Douarin N, Powell L, Roder J, Schnaar RL, Sgroi DC, Stamenkovic K, Schauer R, Schachner M, van den Berg TK, van der Merwe PA, Watt SM, Varki A (1998) Siglecs: a family of sialic-acid binding lectins. Glycobiology 8(2):v
David S, Aguayo AJ (1981) Axonal elongation into peripheral nervous system “bridges” after central nervous system injury in adult rats. Science 214:931–933
De Bellard ME, Filbin MT (1999) Myelin-associated glycoprotein, MAG, selectively binds several neuronal proteins. J Neurosci Res 56:213–218
DeBellard ME, Tang S, Mukhopadhyay G, Shen Y-J, Filbin MT (1996) Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein. Mol Cell Neurosci 7:89–101
Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, Muir E, Levine JM, Geller HM, Rogers JH, Faissner A, Fawcett JW (1999) Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci 19:8778–8788
Fitch MT, Doller C, Combs CK, Landreth GE, Silver J (1999) Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 19:8182–8198
Fournier AE, Strittmatter SM (2001) Repulsive factors and axon regeneration in the CNS. Curr Opin Neurobiol 11:89–94
Fournier AE, GrandPre T, Strittmatter SM (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409:341–346
Fruttiger M, Montag D, Schachner M, Martini R (1995) Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 7:511–515
Fry EJ (2001) Central nervous system regeneration: mission impossible? Clin Exp Pharmacol Physiol 28:253–258
Geisler FH, Coleman WP, Grieco G, Poonian D (2001) Measurements and recovery patterns in a multicenter study of acute spinal cord injury. Spine 26:568–586
Goldberg JL, Barres BA (2000) Nogo in nerve regeneration. Nature 403:369–370
GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403:439–444
Hocking AM, Shinomura T, McQuillan DJ (1998) Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 17:1–19
Huang DW, McKerracher L, Braun PE, David S (1999) A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 24:639–647
Huber AB, Schwab ME (2000) Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol Chem 381:407–419
Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH (2002) NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 22:2792–2803
Kelm S, Pelz A, Schauer R, Filbin MT, Song T, de Bellard ME, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P, Crocker PR (1994) Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol 4:965–972
Kobe B, Deisenhofer J (1994) The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci 19:415–421
Kwon BK, Tetzlaff W (2001) Spinal cord regeneration: from gene to transplants. Spine 26:S13–S22
Lehmann M, Fournier A, Selles-Navarro I, Dergham P, Sebok A, Leclerc N, Tigyi G, McKerracher L (1999) Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 19:7537–7547
Li M, Shibata A, Li C, Braun PE, McKerracher L, Roder J, Kater SB, David S (1996) Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse. J Neurosci Res 46:404–414
Liu Y, Wada R, Kawai H, Sango K, Deng C, Tai T, McDonald MP, Araujo K, Crawley JN, Bierfreund U, Sandhoff K, Suzuki K, Proia RL (1999) A genetic model of substratedeprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 103:497–505
Luo L (2000) Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1:173–180 McKeon RJ, Schreiber RC, Rudge JS, Silver J (1991) Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 11:173–180
McKeon RJ, Jurynec MJ, Buck CR (1999) The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 19:10778–10788
McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE (1994) Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13:805–811
Merkler D, Metz GA, Raineteau O, Dietz V, Schwab ME, Fouad K (2001) Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 21:3665–3673
Moon LD, Asher RA, Rhodes KE, Fawcett JW (2002) Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat. Neuroscience 109:101–117
Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT (1994) A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13:757–767
Niederost BP, Zimmermann DR, Schwab ME, Bandtlow CE (1999) Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J Neurosci 19:8979–8989
Poltorak M, Sadoul R, Keilhauer G, Landa C, Fahrig T, Schachner M (1987) Myelin-associated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuron-oligodendrocyte and oligodendrocyteoligo-dendrocyte interaction. J Cell Biol 105:1893–1899
Prinjha R, Moore SE, Vinson M, Blake S, Morrow R, Christie G, Michalovich D, Simmons DL, Walsh FS (2000) Inhibitor of neurite outgrowth in humans. Nature 403:383–384
Raineteau O, Fouad K, Noth P, Thallmair M, Schwab ME (2001) Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat. Proc Natl Acad Sci USA 98:6929–6934
Schäfer M, Fruttiger M, Montag D, Schachner M, Martini R (1996) Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron 16:1107–1113
Schnaar RL (2000) Glycobiology of the nervous system. In: Ernst B, Hart GW, Sinay P (eds) Carbohydrates in chemistry and biology, part II. Biology of saccharides. WileyVCH, Weinheim, pp 1013–1027
Schwab ME (2002) Repairing the injured spinal cord. Science 295:1029–1031
Schwab ME, Caroni P (1988) Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J Neurosci 8:2381–2393
Schwab ME, Thoenen H (1985) Dissociated neurons regenerate into sciatic but not optic nerve explants in culture irrespective of neurotrophic factors. J Neurosci 5:2415–2423
Sekhon LH, Fehlings MG (2001) Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26:S2–S12
Selles-Navarro I, Ellezam B, Fajardo R, Latour M, McKerracher L (2001) Retinal ganglion cell and nonneuronal cell responses to a microcrush lesion of adult rat optic nerve. Exp Neurol 167:282–289
Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96:7532–7537
Snow DM, Lemmon V, Carrino DA, Caplan AI, Silver J (1990) Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol 109:111–130
Song H, Ming G, He Z, Lehmann M, Tessier-Lavigne M, Poo M (1998) Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 281:1515–1518
Spillmann AA, Bandtlow CE, Lottspeich F, Keller F, Schwab ME (1998) Identification and characterization of a bovine neurite growth inhibitor (bNI-220). J Biol Chem 273:19283–19293
Stoeckli ET, Landmesser LT (1998) Axon guidance at choice points. Curr Opin Neurobiol 8:73–79
Strenge K, Brossmer R, Ihrig P, Schauer R, Kelm S (2001) Fibronectin is a binding partner for the myelin-associated glycoprotein (siglec-4a). FEBS Lett 499:262–267
Sun J, Schnaar RL (2000) Myelin-associated glycoprotein is selectively and progressively downregulated in the central and peripheral nervous systems of complex ganglio-side knockout mice. Glycobiology 10:1087–1088
Svennerholm L (1994) Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog Brain Res 101:xi-xiv
Tettamanti G, Bonali F, Marchesini S, Zambotti V (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 296:160–170
Trapp BD (1990) Myelin-associated glycoprotein. Location and potential functions. Ann NY Acad Sci 605:29–43
Trapp BD, Andrews SB, Cootauco C, Quarles R (1989) The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J Cell Biol 109:2417–2426
Van Vactor D, Flanagan JG (1999) The middle and the end: slit brings guidance and branching together in axon pathway selection. Neuron 22:649–652
Vinson M, Strijbos PJ, Rowles A, Facci L, Moore SE, Simmons DL, Walsh FS (2001) Myelin-associated glycoprotein interacts with ganglioside GT1b: a mechanism for neurite outgrowth inhibition. J Biol Chem 276:20280–20285
Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL (2002) Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA 99:8412–8417
Weiss MD, Luciano CA, Quarles RH (2001) Nerve conduction abnormalities in aging mice deficient for myelin-associated glycoprotein. Muscle Nerve 24:1380–1387
Yang LJS, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL (1996) Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci USA 93:814–818
Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C, Roder J, Trapp BD (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953–1962
Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z, Filbin M (2002) Myelin-associated glycoprotein interacts with the nogo66 receptor to inhibit neurite outgrowth. Neuron 35:283–290
GrandPre T, Li S, Strittmatter SM (2002) Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417:547–551
Liu BP, Fournier A, GrandPre T, Strittmatter SM (2002) Myelin-Associated Glycoprotein as a Functional Ligand for the Nogo-66 Receptor. Science 297:1190–1193
Wang KC, Kim JA, Sivasankaran R, Segal R, He Z (2002a) P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420:74–78
Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z (2002b) Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417:941–944
Yamashita T, Higuchi H, Tohyama M (2002) The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J Cell Biol 157:565–570
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schnaar, R.L. (2003). Myelin Molecules Limiting Nervous System Plasticity. In: Kostović, I. (eds) Guidance Cues in the Developing Brain. Progress in Molecular and Subcellular Biology, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55557-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-55557-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62426-1
Online ISBN: 978-3-642-55557-2
eBook Packages: Springer Book Archive